KARIE HALL: Open Payments
NPI 1275576852 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 37 payments from 14 companies in 2025. Trend: 2023 $592 · 2024 $702 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $149 |
| Arcutis Biotherapeutics, Inc. | 6 | $137 |
| GENZYME CORPORATION | 1 | $111 |
| UCB, Inc. | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Janssen Biotech, Inc. | 3 | $41 |
| Galderma Laboratories, L.P. | 1 | $36 |
| Amgen Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $29 |
| LEO Pharma Inc. | 1 | $28 |
Products named: Zoryve, DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, TREMFYA, AKLIEF, Otezla.
Industry payments across CA — which companies pay providers there.
